Loading...
OTCM
GALNF
Market cap5.34bUSD
Nov 23, Last price  
75.25USD
Name

Galenica AG

Chart & performance

D1W1MN
OTCM:GALNF chart
P/E
17.07
P/S
0.75
EPS
3.63
Vol. 1Y
—
Shs. 5Y
0.16%
Rev. 5Y
3.51%
Div Yld LY
—
Div Yld TTM
—
Revenues
4.14b
+5.47%
2,826,272,0002,914,917,0003,008,851,0003,145,400,0003,171,342,0003,306,237,0003,479,753,0003,834,679,0004,014,348,0003,746,011,0003,921,081,0004,135,621,000
Net income
181m
-1.01%
81,824,00081,122,00083,393,000118,804,000147,546,000124,992,000172,245,000167,680,000165,132,000173,598,000182,951,000181,099,000
CFO
300m
+13.25%
84,118,000132,435,000156,818,000144,399,000173,550,000250,438,000224,360,000333,095,000236,873,000225,710,000264,703,000299,765,000
Dividend
Apr 23, 20261.5937 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Galenica AG, a Bern, Switzerland-based company founded in 1927, functions as a prominent healthcare service provider, operating across Switzerland and on an international scale. Its comprehensive operations are strategically divided into two primary segments: Products & Care, and Logistics & IT. Within the Products & Care division, Galenica manages an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner locations. These operate under established brand names such as Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy management, this segment is also responsible for delivering medication for at-home patient treatment, launching and distributing a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, and providing dedicated marketing and sales assistance to its healthcare industry collaborators. The Logistics & IT segment delivers a suite of specialized pre-wholesale services to pharmaceutical and other healthcare enterprises. These offerings encompass storage, efficient distribution, and debt collection. Furthermore, this division provides broader logistics and IT infrastructure, including a master data system specifically designed for the healthcare sector. It also focuses on developing sophisticated management solutions for the healthcare market and is responsible for publishing both digital and print technical information about pharmaceutical products, in addition to offering comprehensive management platforms for pharmacies.

Key people

Independent Chairman of the Board of Directors · since 2023
Marc Werner
Chief Executive Officer, Member of the Corporate Executive Committee · since 2021
Independent Vice Chairwoman of the Board of Directors · since 2023
Julian Fiessinger
Chief Financial Officer, Member of the Corporate Executive Committee · since 2025
Lukas Ackermann
Chief IT & Digital Business, Member of the Corporate Executive Committee · since 2024
Arianne Hasler
Chief People and Culture Officer, Member of the Corporate Executive Committee · since 2023
Virginie Jeschka
Chief Pharmacies Officer, Member of the Corporate Executive Committee · since 2021
Andreas Koch
Chief Wholesale & Logistics, Member of the Corporate Executive Committee · since 2021
Daniele Madonna
Chief Pharmacies Category Management & Health Services, Member of the Corporate Executive Committee · since 2024
Stephan Mignot
Chief Pharmacies Marketing, Member of the Corporate Executive Committee · since 2024
Thomas Szuran
Chief Products & Home Care, Deputy Chief Executive Officer, Member of the Corporate Executive Committee · since 2025
Barbara Walchli
General Secretary · since 2020
Nadine Balkanyi-Nordmann
Independent Member of the Board of Directors · since 2025
Bertrand Jungo
Independent Member of the Board of Directors · since 2023
Judith Meier
Independent Member of the Board of Directors · since 2022
Solange Peters
Independent Member of the Board of Directors · since 2023
Joerg Zulauf
Independent Member of the Board of Directors · since 2023
IPO date
Apr 07, 2017
Employees
7,673
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
Untermattweg 8
Bern, BE 3027
CH
Other language
Galenica Ltd.
Other language
Galenica SA

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT